Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Yonghe Medical Group Co., Ltd. ( (HK:2279) ) just unveiled an announcement.
Yonghe Medical Group Co., Ltd. announced its annual results for the year ended 31 December 2024, reporting a revenue increase of 1.5% to RMB1,804.5 million and a gross profit increase of 8.7% to RMB1,084.2 million. The company’s net loss narrowed significantly by 58.6% to RMB226.6 million, and it achieved earnings before interest, taxes, depreciation, and amortization (EBITDA) of RMB141.0 million, compared to a loss in the previous year. Despite these improvements, the board decided not to declare any dividends for the year.
More about Yonghe Medical Group Co., Ltd.
Yonghe Medical Group Co., Ltd. operates in the healthcare industry, focusing on providing medical services and products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 27.78%
Average Trading Volume: 234,391
Technical Sentiment Signal: Buy
Current Market Cap: HK$604.3M
See more data about 2279 stock on TipRanks’ Stock Analysis page.